Extended Data Fig. 7: Additional data from EV013-AML. | Nature Medicine

Extended Data Fig. 7: Additional data from EV013-AML.

From: Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers

Extended Data Fig. 7

(a) DSS from clinically available FLT3 inhibitors (b) Top effective single agent drugs (top) followed by physician-selected drug combinations (bottom) (c) Dose-response from steroid agents tested in EV013-AML-derived cells. (n = 1 due to limited PDC material). Data is presented as mean cell viability values +/− SEM. (d) Comparison of time to complete response following previous and FPM-guided regimens.

Back to article page